France to reimburse IGRAs to screen at-risk individuals for latent TB
The French decision to reimburse interferon-gamma release assays (IGRAs) for TB screening includes QuantiFERON-TB® Gold Plus (QFT-Plus®) and T-SPOT®.TB Test.
By Qiagen, Oxford Immunotec
Published: June 28, 2017, 10:50 p.m.
Last updated: June 28, 2017, 10:51 p.m.
